1-4 of 4
Othon L Gervasio
Close
Sort by
Journal Articles

Efficacy and Safety of Nilotinib 300 Mg Twice Daily (BD) in Patients with CML in Chronic Phase (CML-CP) Who Are Intolerant to Prior BCR-ABL Tyrosine Kinase Inhibitors (TKIs): Results from the Randomized, Phase IIIb E.N.E.S.Tswift Study

Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD, Peter Tan, James D'Rozario, John Taper, MBBS FRACP FRCPA, Anthony Richard Powell, FRACP, MBBS, Ian Irving, Matthew P.F. Wright, MBBS, FRCPA, FRACP, Susan Branford, PhD FFSc (RCPA), David T. Yeung, BSc, MBBS, FRACP, FRCPA, Luke Anderson, Othon L Gervasio, Timothy P. Hughes, MD
Journal: Blood
Blood (2016) 128 (22): 5447.
https://doi.org/10.1182/blood.V128.22.5447.5447
Published: 2016
Journal Articles

Prevalence of Cardiac and Hepatic Siderosis in Australian Patients with Transfusion-Dependent Anemias or Non-Transfusion-Dependent Thalassemia, As Assessed By MRI (the TIMES study)

Phoebe Joy Ho, Devendra Hiwase, MBBS, FRACP, FRCPA, MD PhD, Raj Ramakrishna, Nicholas Viiala, David M Ross, MBBS, PhD FRACP, FRCPA, Evren Zor, Othon L Gervasio, Donald Bowden
Journal: Blood
Blood (2015) 126 (23): 540.
https://doi.org/10.1182/blood.V126.23.540.540
Published: 2015
Journal Articles

A Study of Magnetic Resonance Imaging Assessment of Cardiac and Liver Iron Load in Patients with Haemoglobinopathies, Myelodysplastic Syndromes or Other Anaemias Treated with Deferasirox (the MILE study CICL670AAU01) – Results of An Interim Analysis At a Planned Sample Size Reassessment,

P. Joy Ho, MBBS, FRACP, FRCPA, DPhil, Lay Tay, MBBS, FRCPA, Juliana Teo, MBBS, FRCPA, FRACP, Paula Marlton, MBBS, Andrew Grigg, MBBS, FRACP, FRCPA, Tim St. Pierre, PhD, Greg Brown, Fellow SMRT, Othon L Gervasio, DDS, MS, PhD, Donald K Bowden, MD
Journal: Blood
Blood (2011) 118 (21): 3181.
https://doi.org/10.1182/blood.V118.21.3181.3181
Published: 2011
Journal Articles

Determination of the Maximum Tolerated Dose of Panobinostat in Combination with a 5-Day Schedule of Azacitidine in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia: Planned Interim Analysis of a Phase Ib/II Study

Peter T. Tan, MBBS, Kate Reed, BSc, Patricia A. Walker, MBBS, FRACP, FRCPA, Sharon Avery, MBBS, Sushrut S. Patil, FRACP FRCPA, Andrew Grigg, MBBS, FRACP, FRCPA, Peter Mollee, MBBS, FRCPA, FRACP, MMSc, Othon L Gervasio, DDS, MS, PhD, Ivo J. Winiger, MD, Dirk Hönemann, MD, Andrew H Wei, MBBS, PhD, Andrew Spencer, MD
Journal: Blood
Blood (2011) 118 (21): 1529.
https://doi.org/10.1182/blood.V118.21.1529.1529
Published: 2011